Latest News- Gastrointestinal Products Market: Endoscopy devices is expected to lead the Type segment during 2025-2029

The Gastrointestinal Products Market is being driven by Rising prevalence of gastrointestinal disorders

The Gastrointestinal Products Market is expected to grow at a CAGR of 6.5% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 5376.8 million. In the realm of gastrointestinal (GI) diagnostics, the integration of artificial intelligence (AI) into endoscopic devices is revolutionizing the industry. At the Genius Summit 2024 on April 10, 2024, Medtronic plc showcased its latest advancements in AI-driven endoscopic care. The company introduced ColonPRO, an advanced software for the GI Genius intelligent endoscopy system. This next-generation software, which boasts an expanded dataset, enhances polyp detection accuracy by reducing false positives by 9%. Furthermore, ColonPRO offers new procedural highlights that streamline workflows and lessen administrative burdens, thereby increasing the efficiency of endoscopic procedures for healthcare providers. This technological innovation significantly contributes to better patient outcomes by improving real-time image analysis, lesion detection, and polyp classification. 

Get more information on Gastrointestinal Products Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • Endoscopy devices
  • Motility testing devices
  • Ablation devices
  • Biopsy devices
  • Others
• End-user
  • Hospitals
  • Ambulatory surgical centers
  • Others
• Geography
  • North America
    • Canada
    • US
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rising prevalence of gastrointestinal disorders
• Growing aging population
• Increased awareness and early diagnosis of GI diseases

However, the market also witnesses some limitations, which are as follows:

• Regulatory compliance
• Lack of skilled healthcare professionals
• High cost of advanced GI devices

Benefits of Buying Global Gastrointestinal Products Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Gastrointestinal Products Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Gastrointestinal Products Market encompasses a range of offerings aimed at promoting health and managing various conditions, including inflammatory bowel disease (IBD), Crohn's disease, and other digestive disorders. Over-the-counter medications and rectal medications offer relief from pain and discomfort, while therapies like endoscopy and surgery provide more intensive treatment. Specialist care and patient education are crucial for effective disease management. Prevention through nutritional supplements, prebiotics, probiotics, and functional foods targets chronic diseases and gut health. Biomarkers, immune system support, and genetic testing contribute to disease burden reduction and healthcare cost savings. Inflammation, motility, and gut microbiome are key areas of focus for disease prevention and healthspan enhancement. Cancer prevention and intestinal health are significant aspects of this market.

Market Research Overview

The gastrointestinal products market encompasses the revenue generated from the sales of antidiarrheal medications, OTC drugs, and prescription therapies such as biological medications and anti-inflammatory drugs. This market size is calculated by Technavio, taking into account the combined revenue of manufacturers and providers in the healthcare sector, including those specializing in equipment, supplies, pharmaceuticals, biotechnology, healthcare technology, and life sciences tools and services. Factors driving market growth include the need to reduce healthcare costs, regulatory approvals for innovative treatments like upadacitinib for gastrointestinal conditions such as gastroenteritis and asthma, and the integration of technology in healthcare delivery.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/